Markets:

Overview

News

Currencies

International

Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

3.800 +0.140 (+3.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

29 30 Next >

Psychedelic Stock Gainers And Losers From November 23, 2022 ↗

November 23, 2022

Via Benzinga

Tesla, Deere And Some Other Big Stocks Moving Higher On Wednesday ↗

November 23, 2022

U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue ↗

November 23, 2022

(Part three of a four-part series) Have a look at previous stories:

Via Benzinga

Psychedelic Stock Gainers And Losers From November 22, 2022 ↗

November 22, 2022

Via Benzinga

Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark ↗

November 22, 2022

Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.

Via Benzinga

Psychedelic Stock Gainers And Losers From November 21, 2022 ↗

November 21, 2022

Via Benzinga

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗

November 21, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Psychedelic Drug Stocks Index Continued To Decline Last Week ↗

November 20, 2022

This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...

Via Talk Markets

Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

November 18, 2022

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 17, 2022

Via Benzinga

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment

November 17, 2022

From atai Life Sciences

Via GlobeNewswire

Psychedelic Stock Gainers And Losers From November 16, 2022 ↗

November 16, 2022

Via Benzinga

GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 15, 2022

Via Benzinga

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗

November 15, 2022

Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

Via Benzinga

Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates

November 14, 2022

EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END

Via FinancialNewsMedia

Topics Retirement

360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 14, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗

November 14, 2022

We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...

Via Talk Markets

Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗

November 10, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05

Via Benzinga

Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute' ↗

November 10, 2022

Clinical-stage psychedelics company atai Life Sciences N.V. (NASDAQ: ATAI) reported its financial results for the quarter ended September 30, 2022 and shared business developments.

Via Benzinga

atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update

November 10, 2022

From atai Life Sciences

Via GlobeNewswire

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 09, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From November 8, 2022 ↗

November 08, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14

Via Benzinga

The Psychedelic Drug Stocks Index Continued To Plummet Last Week ↗

November 07, 2022

In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.

Via Talk Markets

Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More ↗

November 07, 2022

Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'

Via Benzinga

Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗

November 07, 2022

GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44

Via Benzinga

These Are The Top Companies And Most Influential People In The Psychedelics Space: Meet The Winners Of The Microdose Awards ↗

November 07, 2022

Which are the top companies and who are the most influential people in the psychedelics space? According to Microdose Psychedelic Insights, host of the Microdose Awards, these are the ones to watch.

Via Benzinga

EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗

November 07, 2022

(Part four of a four-part series) See previous stories in this series:

Via Benzinga

Women in Psychedelics Announces atai as Platinum Sponsors

November 04, 2022

From Women in Psychedelics Network

Via Business Wire

EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' ↗

November 04, 2022

Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a...

Via Benzinga

Psychedelic Stock Gainers And Losers From November 3, 2022 ↗

November 03, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atai Beckley N.V - Common Shares (NQ:ATAI)

All News about Atai Beckley N.V - Common Shares

Starting at $3.75/week.

Subscribe Today